Navigation Links
Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA
Date:9/20/2011

REDWOOD CITY, Calif., Sept. 20, 2011 – Ingenuity® Systems, a leading provider of information and analytics solutions for life science researchers, today announced the addition of new experimentally validated microRNA-mRNA target interactions from miRecords, plus thousands of additional miRNA-mRNA interactions manually curated from additional peer-reviewed literature. The newly added content supplements existing experimentally demonstrated and predicted miRNA targets in IPA, and will be used by IPA's microRNA Target Filter to help researchers quickly and reliably prioritize miRNA target interactions.  

"IPA and its microRNA Target Filter have been very impactful for our research," stated Arupa Ganguly, Ph.D. Professor of Genetics at the Hospital of the University of Pennsylvania. "We compared gene expression signatures of matched normal retinal tissue and retinoblastoma tumor tissue, and then used IPA for biological analysis of the data.  Using microRNA and mRNA from same tumors, we applied the microRNA Target Filter in combination with the content in IPA. This approach helped us rapidly narrow in on key microRNAs we thought to be involved with tumor progression."   

Today, there is no other software tool on the market that has this powerful combination of microRNA tools and content in one place. IPA allows researchers to examine both predicted and experimentally demonstrated microRNA-mRNA pairings, prioritize targets based on relevant biological context, and visualize the molecular interactions of those target relationships and related biological impacts. This streamlines a workflow that previously took days: researchers can now take lists of over 13,000 potential targets down to just 2 of the most biologically relevant in a matter of minutes.

For more information about the new microRNA Target Filter and content in IPA, please go to our product page or watch the microRNA video.

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com


'/>"/>
SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research
2. Ingenuity Announces RNA-Sequencing Workflow Support and First-of-Its-Kind microRNA Filtering Capability With Latest Release of IPA
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology:
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):